Hoda Gheitasi

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome.

Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome.

Journal: Frontiers in medicine

Published: November 25, 2021

Erratum to: Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.

Erratum to: Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.

Journal: Drugs

Published: December 02, 2016

Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.

Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.

Journal: Drugs

Published: November 16, 2016

Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients.

Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients.

Journal: Rheumatology (Oxford, England)

Published: August 13, 2015

How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.

How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.

Journal: Arthritis research & therapy

Published: April 21, 2015

How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patients.

How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patients.

Journal: International immunopharmacology

Published: January 13, 2015

Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies.

Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies.

Journal: Seminars in arthritis and rheumatism

Published: August 18, 2014

Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.

Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.

Journal: Annals of the rheumatic diseases

Published: August 05, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026